Michael Schmiederer, PhD, S(ACHI)

Dr Schmiederer earned his PhD in microbiology and immunology from the University of South Florida College of Medicine. Prior to that, he graduated from Florida Atlantic University with a bachelor of science degree in medical technology. He is certified by the American College for Histocompatibility and Immunogenetics and holds memberships with the American Society for Histocompatibility and Immunogenetics and the Association for the Advancement of Blood & Biotherapies.

Michael Schmiederer, PhD, S(ACHI)

Dr Schmiederer earned his PhD in microbiology and immunology from the University of South Florida College of Medicine. Prior to that, he graduated from Florida Atlantic University with a bachelor of science degree in medical technology. He is certified by the American College for Histocompatibility and Immunogenetics and holds memberships with the American Society for Histocompatibility and Immunogenetics and the Association for the Advancement of Blood & Biotherapies.

Eric M. O’Neill, PhD

Dr O’Neill graduated with a PhD from Utah State University, and he specializes in population genetics and relationship testing. He has more than two decades of experience with population genetics, statistics, and optimal approaches to problem solving. As associate technical director for DNA identification testing at Labcorp, some of his current challenges include utilizing different types of genetic data for complex relationship testing and efficiently identifying most likely pedigrees.

Eric M. O’Neill, PhD

Dr O’Neill graduated with a PhD from Utah State University, and he specializes in population genetics and relationship testing. He has more than two decades of experience with population genetics, statistics, and optimal approaches to problem solving. As associate technical director for DNA identification testing at Labcorp, some of his current challenges include utilizing different types of genetic data for complex relationship testing and efficiently identifying most likely pedigrees.

James Kyle Farquhar, PhD

Dr Farquhar is a board-certified clinical chemist through the National Registry of Certified Chemists. He earned a PhD in health services management from Century University.

Dr Farquhar has several decades of experience in laboratory medicine, including expertise in routine chemistry, toxicology, clinical laboratory regulations, and technical customer service.

Dr Farquhar also has served as a member of the American Association for Clinical Chemistry.

James Kyle Farquhar, PhD

Dr Farquhar is a board-certified clinical chemist through the National Registry of Certified Chemists. He earned a PhD in health services management from Century University.

Dr Farquhar has several decades of experience in laboratory medicine, including expertise in routine chemistry, toxicology, clinical laboratory regulations, and technical customer service.

Dr Farquhar also has served as a member of the American Association for Clinical Chemistry.

Chevonne Eversley, PhD, DABMG

Dr Eversley earned her PhD in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill. She completed her postdoctoral training in molecular genetics at Mount Sinai School of Medicine in New York, and she is a fellow of the American College of Medical Genetics.

Dr Eversley is co-discipline director of the molecular genetics, genomic sequencing, and prenatal genomic screening laboratories at the Center for Molecular Biology and Pathology. She is responsible for oversight of molecular genetic interests at the facility.

Chevonne Eversley, PhD, DABMG

Dr Eversley earned her PhD in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill. She completed her postdoctoral training in molecular genetics at Mount Sinai School of Medicine in New York, and she is a fellow of the American College of Medical Genetics.

Dr Eversley is co-discipline director of the molecular genetics, genomic sequencing, and prenatal genomic screening laboratories at the Center for Molecular Biology and Pathology. She is responsible for oversight of molecular genetic interests at the facility.

Zahra Shajani-Yi, PhD, DABCC

Dr Shajani-Yi earned her PhD from the University of Washington and completed her clinical chemistry fellowship at Dartmouth-Hitchcock Medical Center, in the Department of Pathology and Laboratory Medicine. She is a diplomate of the American Board of Clinical Chemistry (DABCC), a fellow of the American Association for Clinical Chemistry Academy (FAACC), and board-certified by the National Registry of Certified Chemists (NRCC). Prior to joining Labcorp, she was an assistant professor at Vanderbilt University School of Medicine and Medical Director of Esoteric Chemistry.

Zahra Shajani-Yi, PhD, DABCC

Dr Shajani-Yi earned her PhD from the University of Washington and completed her clinical chemistry fellowship at Dartmouth-Hitchcock Medical Center, in the Department of Pathology and Laboratory Medicine. She is a diplomate of the American Board of Clinical Chemistry (DABCC), a fellow of the American Association for Clinical Chemistry Academy (FAACC), and board-certified by the National Registry of Certified Chemists (NRCC). Prior to joining Labcorp, she was an assistant professor at Vanderbilt University School of Medicine and Medical Director of Esoteric Chemistry.